Related references
Note: Only part of the references are listed.EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
Axel Heidenreich et al.
EUROPEAN UROLOGY (2014)
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent-Update 2013
Axel Heidenreich et al.
EUROPEAN UROLOGY (2014)
11C-Choline PET/CT Predicts Prostate Cancer-Specific Survival in Patients with Biochemical Failure During Androgen-Deprivation Therapy
Giampiero Giovacchini et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
11C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy
Francesco Ceci et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Role of 18F-choline PET/CT in suspicion of relapse following definitive radiotherapy for prostate cancer
Sotirios Chondrogiannis et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
18F-Fluoroethylcholine PET/CT Identifies Lymph Node Metastasis in Patients with Prostate-Specific Antigen Failure After Radical Prostatectomy but Underestimates Its Extent
Derya Tilki et al.
EUROPEAN UROLOGY (2013)
Survival Following Biochemical Recurrence After Radical Prostatectomy and Adjuvant Radiotherapy in Patients With Prostate Cancer: The Impact of Competing Causes of Mortality and Patient Stratification
Firas Abdollah et al.
EUROPEAN UROLOGY (2013)
Impact of 18F-Choline PET/CT in Prostate Cancer Patients with Biochemical Recurrence: Influence of Androgen Deprivation Therapy and Correlation with PSA Kinetics
Mohsen Beheshti et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
[C-11] Choline Positron Emission Tomography/Computerized Tomography for Early Detection of Prostate Cancer Recurrence in Patients with Low Increasing Prostate Specific Antigen
Giampiero Giovacchini et al.
JOURNAL OF UROLOGY (2013)
[C-11]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy
Maria Picchio et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
F-18-Fluoromethylcholine (FCH) PET imaging in patients with castration-resistant prostate cancer: prospective comparison with standard imaging
Michael McCarthy et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Is there a role for C-11-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase < 1.5 ng/ml?
Paolo Castellucci et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed Tomography
Patrizio Rigatti et al.
EUROPEAN UROLOGY (2011)
End Points and Outcomes in Castration-Resistant Prostate Cancer: From Clinical Trials to Clinical Practice
Howard I. Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Influence of 11C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer
Michael Souvatzoglou et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Predictive factors of [11C]choline PET/CT in patients with biochemical failure after radical prostatectomy
Giampiero Giovacchini et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
PSA doubling time for prediction of [11C]choline PET/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy
Giampiero Giovacchini et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
[11C]Choline Positron Emission Tomography/Computerized Tomography to Restage Prostate Cancer Cases With Biochemical Failure After Radical Prostatectomy and No Disease Evidence on Conventional Imaging
Giampiero Giovacchini et al.
JOURNAL OF UROLOGY (2010)
The Use of F-18 Choline PET in the Assessment of Bone Metastases in Prostate Cancer: Correlation with Morphological Changes on CT
Mohsen Beheshti et al.
MOLECULAR IMAGING AND BIOLOGY (2010)
Influence of Trigger PSA and PSA Kinetics on 11C-Choline PET/CT Detection Rate in Patients with Biochemical Relapse After Radical Prostatectomy
Paolo Castellucci et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer
David Schilling et al.
BJU INTERNATIONAL (2008)
Increased C-11 Choline Uptake in Pagetic Bone in a Patient With Coexisting Skeletal Metastases From Prostate Cancer
Giampiero Giovacchini et al.
CLINICAL NUCLEAR MEDICINE (2008)
Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy
Bruce J. Trock et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Evaluation of [18F]-choline PET/CT for staging and restaging of prostate cancer
Daniela B. Husarik et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
The detection rate of [C-11]Choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer
B. J. Krause et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Evaluation of [11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer
Ludwig Rinnab et al.
BJU INTERNATIONAL (2007)
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
Andrew J. Stephenson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Death in patients with recurrent prostate cancer after radical prostatectomy: Prostate-specific antigen doubling time subgroups and their associated contributions to all-cause mortality
Stephen J. Freedland et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
F-18-choline and/or C-11-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (< 1 ng/mL) after radical prostatectomy
Hansjoerg Vees et al.
BJU INTERNATIONAL (2007)
Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy
P Zhou et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy
SJ Freedland et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Fluorodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimiorotubule chemotherapy
MJ Morris et al.
CLINICAL CANCER RESEARCH (2005)
Value of [11C]choline-positron emission tomography for re-staging prostate cancer:: A comparison with [18F]fluorodeoxyglucose-positron emission tomography
M Picchio et al.
JOURNAL OF UROLOGY (2003)
Comparison of [18F]fluorocholine and [18F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer
DT Price et al.
JOURNAL OF UROLOGY (2002)
Share Paper
